menu
    • menu

    Company profile for Formycon

    NEW Drugs in Dev: 7
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Formycon is a world-leading, independent developer of high-quality biosimilars, meaning follow-on products to biopharmaceutical medicines already on the market. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Our company’s activities span the entire range from technical- pharmaceutical development to clinical trials all the way through to preparation and submission of dos...
    Formycon is a world-leading, independent developer of high-quality biosimilars, meaning follow-on products to biopharmaceutical medicines already on the market. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Our company’s activities span the entire range from technical- pharmaceutical development to clinical trials all the way through to preparation and submission of dossiers for regulatory approval. We develop biosimilar medicines to meet the high standards of the world’s most stringently regulated markets: the European Union, the United States, Canada, Japan and Australia.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    FormyconGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Formycon AG Fraunhoferstraße 15 82152 Martinsried/Planegg
    Telephone
    Telephone
    +49 89 864667 100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.formycon.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/formycon
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/formycon

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zydus' Keytruda Biosimilar Succeeds in FYB206 Trial
    Zydus' Keytruda Biosimilar Succeeds in FYB206 Trial

    28 Feb 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/zydus-hits-keytruda-biosimilar-milestone-with-successful-fyb206-trial-targets-usfda-filing-19237

    INDPHARMAPOST
    28 Feb 2026
    Share Share
    Formyn AG’s Biologics Nufymco Receives Approval in US
    Formyn AG’s Biologics Nufymco Receives Approval in US

    18 Dec 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761473

    FDA
    18 Dec 2025
    Share Share
    Zydus, Formycon Partner For Exclusive Biosimilar Supply
    Zydus, Formycon Partner For Exclusive Biosimilar Supply

    09 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zydus-and-formycon-enter-into-an-exclusive-partnership-for-the-licensing-and-supply-of-biosimilar-to-keytruda-pembrolizumab-in-us-and-canada-302636647.html

    PR NEWSWIRE
    09 Dec 2025
    Share Share
    Formycon, MS Pharma Partner On Exclusive Keytruda Biosimilar
    Formycon, MS Pharma Partner On Exclusive Keytruda Biosimilar

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formycon-and-ms-pharma-sign-exclusive-commercialization-partnership-for-keytruda-biosimilar-candidate-fyb206-for-the-mena-region-302632836.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share
    Formycon AG Research by First Berlin Equity Research
    Formycon AG Research by First Berlin Equity Research

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/original-research-formycon-ag-von-first-berlin-equity-research-gmbh

    PHARMAWEB
    17 Sep 2025
    Share Share
    Horus Pharma Partners with Formycon for Eylea Biosimilar
    Horus Pharma Partners with Formycon for Eylea Biosimilar

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/horus-pharma-becomes-additional-commercialization-partner-for-formycons-eylea-biosimilar-fyb203-in

    PHARMAWEB
    17 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search